Orin Hirschman 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-27 08:09 am Purchase | 2026-03-31 | 13G | APREA THERAPEUTICS INC APRE | Orin Hirschman | 1,186,294 9.900% | 534,547 (+82.02%) | Filing |
| 2026-01-28 2:02 pm Purchase | 2025-12-31 | 13G | APREA THERAPEUTICS INC APRE | Orin Hirschman | 651,747 9.900% | 112,447 (+20.85%) | Filing |
| 2025-02-10 08:36 am Purchase | 2024-12-31 | 13G | APREA THERAPEUTICS INC APRE | Orin Hirschman | 539,300 9.900% | 190,000 (+54.39%) | Filing |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | APREA THERAPEUTICS INC APRE | Orin Hirschman | 349,300 11.000% | 4,300 (+1.25%) | Filing |
| 2023-03-03 06:03 am Purchase | 2023-02-23 | 13G | APREA THERAPEUTICS INC APRE | Orin Hirschman | 345,000 11.000% | 345,000 (New Position) | Filing |